Correction to: European Journal of Nuclear Medicine and Molecular Imaging
The headings of Figure 4 were corrected after the initial publication.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Unterrainer, M., Kunte, S.C., Unterrainer, L.M. et al. Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [18F]SiTATE. Eur J Nucl Med Mol Imaging 50, 4115 (2023). https://doi.org/10.1007/s00259-023-06409-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-023-06409-8